LEO Pharma

LEO Pharma's History

Founded in 1908, LEO Pharma has a rich history rooted in Denmark. Over the years, the company has evolved from a small pharmacy into a global leader in medical dermatology. A significant milestone in its history was the development of the first Danish drug to be exported, showcasing its pioneering spirit. The company has continuously expanded its reach and now operates with affiliates in multiple countries worldwide, reflecting its commitment to bringing innovative treatments to patients across the globe.

LEO Pharma's Focus Areas

LEO Pharma is dedicated to the treatment of dermatological conditions such as psoriasis, eczema, acne, and skin infections. The company has a specialized division for thrombosis products, further diversifying its therapeutic portfolio. By focusing on these areas, LEO Pharma addresses significant unmet medical needs, providing relief to patients suffering from chronic skin conditions. The company's robust pipeline of early and late-stage assets underscores its commitment to advancing dermatological therapies.

LEO Pharma's Research and Development

LEO Pharma invests heavily in research and development, allocating 13% of its turnover to R&D. This substantial investment fuels the company's innovation engine, allowing it to maintain a strong pipeline of promising therapeutic candidates. LEO Pharma collaborates with academia, biotech, and other pharma companies to enhance its R&D capabilities, ensuring that it remains at the forefront of dermatological research. The company's commitment to transparency in clinical trials further solidifies its reputation as a trustworthy and innovative leader in the field.

LEO Pharma's Corporate Governance and CSR

LEO Pharma operates with a proactive and transparent corporate governance structure, ensuring accountability and ethical business practices. Majority owned by the LEO Foundation, one of Denmark’s largest commercial foundations, the company maintains a business-driven approach to corporate social responsibility (CSR). It is committed to operating sustainably and minimizing its environmental impact. The LEO Foundation also provides philanthropic grants to support international research in skin diseases, reflecting the company's broader commitment to improving global health.

LEO Pharma's Patient-Centric Approach

At the heart of LEO Pharma's operations is a strong focus on patient needs. The company collaborates with healthcare professionals and organizations to enhance patient care, ensuring that its treatments are both effective and accessible. LEO Pharma supports patient organizations and advocates for better healthcare access for individuals with skin diseases. This patient-centric approach is evident in its commitment to transparency in clinical trials and interactions with healthcare professionals, fostering trust and improving outcomes for patients worldwide.